| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |